Epidemiological, clinical, and therapeutic aspects of primary intracerebral hemorrhage

Neurological Sciences

Volumn 29, Issue SUPPL. 2, 2008, Pages

  Ciccone, Alfonso ^a   Pozzi, Mario ^a   Motto, Cristina ^a   Tiraboschi, Pietro ^a   Sterzi, Roberto ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Hemostatic treatment; Primary intracerebral hemorrhage; Randomized controlled trial; Recombinant activated factor VII; Tranexamic acid

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INCIDENCE; MORTALITY; SUBARACHNOID HEMORRHAGE; THROMBOEMBOLISM;

ANTIFIBRINOLYTIC AGENTS; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; COAGULANTS; DRUG ADMINISTRATION SCHEDULE; EARLY DIAGNOSIS; FACTOR VIIA; HUMANS; RECOMBINANT PROTEINS; TIME FACTORS; TRANEXAMIC ACID;

EID: 53649091448     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0955-9     Document Type: Conference Paper

References (4)

1. Counsell C, Boonyakarnkul S, Dennis M et al (1995) Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project. 2. Prognosis. Cerebrovasc Dis 5:26-34
2. Brott T, Broderick J, Kothari R et al (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1-5
3. Mayer SA, Brun NC, Begtrup K et al (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777-785
4. Roos YBWEM, Rinkel GJE, Vermeulen M et al (2003) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD001245. DOI: 10.1002/ 14651858